Dear Prof CERASALE MORTEO,
We thought you might be interested in seeing what our current top three most highly accessed articles* are in the open access journal, Orphanet Journal of Rare Diseases. Check out the below to see what your colleagues are reading right now.
We thought you might be interested in seeing what our current top three most highly accessed articles* are in the open access journal, Orphanet Journal of Rare Diseases. Check out the below to see what your colleagues are reading right now.
Highly Accessed Articles
| REVIEW | ||
| Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency | ||
| Wassenberg et al. | ||
| REVIEW | ||
| Gingival fibromatosis: clinical, molecular and therapeutic issues | ||
| Gawron et al. | ||
| RESEARCH | ||
| Impacts of caring for a child with the CDKL5 disorder on parental wellbeing and family quality of life | ||
| Mori et al. | ||
Interested in publishing your next article with BioMed Central? Here are a few ways we support our authors:
| • | Making research more accessible with Figshare – to allow our authors to make all of their research outputs available in a citable, shareable and discoverable manner |
| • | Standardising our research data policies – to help our authors achieve good practice in the sharing and archiving of research data, and compliance with their research funder and institution requirements |
| • | Institutional membership – we partner with over 500 institutes to help make the funding and billing process as simple as possible. Check here to see if your institute is a member. |
Register to receive the latest articles, straight to your inbox.
Kind regards,
Your BioMed Central Team
Your BioMed Central Team
* Articles are the most highly accessed in the past 30 days according to COUNTER and published in the past 12 months as of January 2017
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.
No hay comentarios:
Publicar un comentario